Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20201104003
TCTR20201104003
Recruiting
Phase 2

The study of clinical effectiveness and safety of a combination of 0.4% minoxidil and 0.05% retinaldehyde nanoparticles solution for treatment of androgenetic alopecia

ermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital0 sites30 target enrollmentNovember 4, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAndrogenetic alopeciaAndrogenetic AlopeciaFemale pattern hair lossTopical nanominoxidilTopical retinaldehyde nanoparticles

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Androgenetic alopecia
Sponsor
ermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital
Enrollment
30
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 4, 2020
End Date
May 31, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\.Patient with androgenetic alopecia with Norwood\-Hamilton grade 3\-4 or Ludwig
  • •2\.Volunteers who have well adherence and can be followed up as appointed grade 1\-2

Exclusion Criteria

  • •1\.Prior treatment of androgenetic alopecia with topical therapy within 3 months
  • •2\.Prior treatment of androgenetic alopecia with oral therapy within 6 months
  • •3\.Prior treatment of androgenetic alopecia with hair transplantation within 12 months
  • •4\.Pregnancy or breastfeeding
  • •5\.Hirsutism
  • •6\.Abnormal thyroid function
  • •7\.Iron deficiency anemia
  • •8\.Patient recieved contraception or hormone replacement therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastases
JPRN-UMIN000012441Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25
Not yet recruiting
Phase 4
Clinical Study on the Effectiveness and Safety of Guanxinning Tablets on Coronary Heart Disease Complicated with Diabetic Nephropathy
ITMCTR2100005416Affiliated Hospital of Hangzhou Normal University
Completed
Not Applicable
Investigation for clinical efficacy and safety of ipragliflozin 50mg and 100mg on type 2 diabetesType 2 diabetes
JPRN-UMIN000016131Osaka Saiseikai Nakatsu Hospital Division of diabetes and endocrinology600
Recruiting
Phase 3
A clinical study to evaluate the efficacy and safety of the Vamana karma followed with two Rasayanas Takradhara and Rasaoushadi in treatment of psoriasis.Health Condition 1: null- Psoriasis (Kitibha)
CTRI/2016/02/006631Central council for Research in Ayurvedic sciences CCRAS110
Completed
Not Applicable
Evaulation of the clinical efficacy and safety of the combined administration of Imidafenacin and Tamsulosin in BPH patients (in which OAB symptoms remain) who did not respond to alpha-1 blocker monotherapy.Overactive bladder
JPRN-UMIN000005012Department of Urology, University of Yamanashi, School of Medicine300